tiprankstipranks
SCYNEXIS (SCYX)
NASDAQ:SCYX
US Market
SCYX
SCYNEXIS
RESEARCH TOOLSreports
Want to see SCYX full AI Analyst Report?

SCYNEXIS (SCYX) Stock News & Sentiment

1,563 Followers
SCYNEXIS Stockholders Approve One-for-Eight Reverse Split
Premium
Company Announcements
SCYNEXIS Stockholders Approve One-for-Eight Reverse Split
21h ago
8K
SCYX
Buy Rating Reaffirmed on Scynexis as Rare Disease Pivot and Strong Cash Runway Support Unchanged $4 Price Target
Premium
Ratings
Buy Rating Reaffirmed on Scynexis as Rare Disease Pivot and Strong Cash Runway Support Unchanged $4 Price Target
10d ago
SCYX
SCYNEXIS Director Steven Gilman Announces Board Retirement
Premium
Company Announcements
SCYNEXIS Director Steven Gilman Announces Board Retirement
1M ago
8K
SCYX
Scynexis: Strategic Pivot to Rare Disease With ADPKD Asset, Strengthened Balance Sheet, and Antifungal Optionality Support Buy Rating and $4 Target
Premium
Ratings
Scynexis: Strategic Pivot to Rare Disease With ADPKD Asset, Strengthened Balance Sheet, and Antifungal Optionality Support Buy Rating and $4 Target
1M ago
SCYX
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
Premium
Company Announcements
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
2M ago
8K
SCYX
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
Premium
Company Announcements
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
2M ago
8K
SCYX
SCYNEXIS Raises $40 Million in Strategic Private Placement
Premium
Company Announcements
SCYNEXIS Raises $40 Million in Strategic Private Placement
2M ago
8K
SCYX
More SCYX News >

SCYX News on the Web

SCYNEXIS (SCYX) Announces 1-for-8 Reverse Stock Split to Meet Nasdaq Requirements
GuruFocus News
Neutral
SCYNEXIS Stockholders Approve One-for-Eight Reverse Split
TipRanks News
Bearish
Scynexis announces 1-for-8 reverse stock split
TipRanks News
Neutral
SCYNEXIS Inc Extraordinary Shareholders Meeting Transcript
GuruFocus News
Neutral
Buy Rating Reaffirmed on Scynexis as Rare Disease Pivot and Strong Cash Runway Support Unchanged $4 Price Target
TipRanks News
Bullish
Scynexis reports Q1 EPS (42c), consensus (12c)
TipRanks News
Bullish
Scynexis files to sell 87M shares of common stock for holders
TipRanks News
Neutral
SCYNEXIS Director Steven Gilman Announces Board Retirement
TipRanks News
Neutral

News Score - Last 7 Days

Very Negative
SCYX
Sector Average
Media Buzz
This Week4 articles
Weekly Average1 articles
News Sentiment
This Week0%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SCYX’s Media Buzz Sentiment?
4 articles about SCYX were published this week. In an average week, 1 articles are published.
    What is SCYX’s weekly average amount of articles?
    In an average week, 1 articles about SCYX are published.
      What is SCYX’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      ILAIsland Pharmaceuticals Ltd
      TLSATiziana Life Sciences
      Showing the stocks with the most bullish news sentiment over the past week